7-144363372-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_005435.4(ARHGEF5):āc.703C>Gā(p.Gln235Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0 ( 0 hom., cov: 26)
Exomes š: 0.0000056 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ARHGEF5
NM_005435.4 missense
NM_005435.4 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.383
Genes affected
ARHGEF5 (HGNC:13209): (Rho guanine nucleotide exchange factor 5) Rho GTPases play a fundamental role in numerous cellular processes initiated by extracellular stimuli that work through G protein coupled receptors. The encoded protein may form a complex with G proteins and stimulate Rho-dependent signals. This protein may be involved in the control of cytoskeletal organization. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.07089302).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF5 | NM_005435.4 | c.703C>G | p.Gln235Glu | missense_variant | 2/15 | ENST00000056217.10 | NP_005426.2 | |
ARHGEF5 | XM_017012623.3 | c.703C>G | p.Gln235Glu | missense_variant | 2/6 | XP_016868112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF5 | ENST00000056217.10 | c.703C>G | p.Gln235Glu | missense_variant | 2/15 | 1 | NM_005435.4 | ENSP00000056217 | P1 | |
ARHGEF5 | ENST00000498580.5 | c.184+519C>G | intron_variant | 3 | ENSP00000417979 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 146838Hom.: 0 Cov.: 26 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
146838
Hom.:
Cov.:
26
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000328 AC: 8AN: 243646Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132556
GnomAD3 exomes
AF:
AC:
8
AN:
243646
Hom.:
AF XY:
AC XY:
3
AN XY:
132556
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000555 AC: 8AN: 1440168Hom.: 0 Cov.: 33 AF XY: 0.00000419 AC XY: 3AN XY: 716760
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
8
AN:
1440168
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
716760
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 146838Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 71646
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
146838
Hom.:
Cov.:
26
AF XY:
AC XY:
0
AN XY:
71646
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2022 | The c.703C>G (p.Q235E) alteration is located in exon 2 (coding exon 1) of the ARHGEF5 gene. This alteration results from a C to G substitution at nucleotide position 703, causing the glutamine (Q) at amino acid position 235 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Gain of sheet (P = 0.0477);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at